These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 19556961)

  • 21. A plasma microRNA biomarker of melanoma as a personalised assessment of treatment response.
    van Laar RK; Lincoln MT; van Laar BJ
    Melanoma Res; 2019 Feb; 29(1):19-22. PubMed ID: 30320629
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Circulating prognosis markers in melanoma: proteomic profiling and clinical studies].
    Solassol J; Guillot B; Maudelonde T
    Ann Biol Clin (Paris); 2011; 69(2):151-7. PubMed ID: 21464007
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gene expression profiling and clinical outcome in melanoma: in search of novel prognostic factors.
    Winnepenninckx V; van den Oord JJ
    Expert Rev Anticancer Ther; 2007 Nov; 7(11):1611-31. PubMed ID: 18020928
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MicroRNAs in cutaneous melanoma: Role as diagnostic and prognostic biomarkers.
    Ross CL; Kaushik S; Valdes-Rodriguez R; Anvekar R
    J Cell Physiol; 2018 Jul; 233(7):5133-5141. PubMed ID: 29226953
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Emerging Biomarkers in Cutaneous Melanoma.
    Eisenstein A; Gonzalez EC; Raghunathan R; Xu X; Wu M; McLean EO; McGee J; Ryu B; Alani RM
    Mol Diagn Ther; 2018 Apr; 22(2):203-218. PubMed ID: 29411301
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HOTAIR role in melanoma progression and its identification in the blood of patients with advanced disease.
    Cantile M; Scognamiglio G; Marra L; Aquino G; Botti C; Falcone MR; Malzone MG; Liguori G; Di Bonito M; Franco R; Ascierto PA; Botti G
    J Cell Physiol; 2017 Dec; 232(12):3422-3432. PubMed ID: 28067428
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gene expression profiling of primary cutaneous melanoma.
    Winnepenninckx V; Van den Oord JJ
    Verh K Acad Geneeskd Belg; 2007; 69(1):23-45. PubMed ID: 17427873
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Liquid Biopsy: Value for Melanoma Therapy.
    Buder-Bakhaya K; Machiraju D; Hassel JC
    Oncol Res Treat; 2017; 40(7-8):430-434. PubMed ID: 28728158
    [No Abstract]   [Full Text] [Related]  

  • 29. The prognostic role of detection of circulating melanoma cells in the blood.
    Dutcher JP
    J Clin Oncol; 2003 Mar; 21(5):757-9. PubMed ID: 12610168
    [No Abstract]   [Full Text] [Related]  

  • 30. Elevated Levels of SOX10 in Serum from Vitiligo and Melanoma Patients, Analyzed by Proximity Ligation Assay.
    Blokzijl A; Chen LE; Gustafsdottir SM; Vuu J; Ullenhag G; Kämpe O; Landegren U; Kamali-Moghaddam M; Hedstrand H
    PLoS One; 2016; 11(4):e0154214. PubMed ID: 27110718
    [TBL] [Abstract][Full Text] [Related]  

  • 31. T-cell receptor diversity as a prognostic biomarker in melanoma patients.
    Charles J; Mouret S; Challende I; Leccia MT; De Fraipont F; Perez S; Plantier N; Plumas J; Manuel M; Chaperot L; Aspord C
    Pigment Cell Melanoma Res; 2020 Jul; 33(4):612-624. PubMed ID: 31971658
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A pilot study of chromosomal aberrations and epigenetic changes in peripheral blood samples to identify patients with melanoma.
    Jakub JW; Grotz TE; Jordan P; Hunter E; Pittelkow M; Ramadass A; Akoulitchev A; Markovic S
    Melanoma Res; 2015 Oct; 25(5):406-11. PubMed ID: 26225582
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Correlation of histopathologic characteristics to protein expression and function in malignant melanoma.
    Welinder C; Pawłowski K; Szasz AM; Yakovleva M; Sugihara Y; Malm J; Jönsson G; Ingvar C; Lundgren L; Baldetorp B; Olsson H; Rezeli M; Laurell T; Wieslander E; Marko-Varga G
    PLoS One; 2017; 12(4):e0176167. PubMed ID: 28445515
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Level of Evidence Review for a Gene Expression Profile Test for Cutaneous Melanoma.
    Dubin DP; Dinehart SM; Farberg AS
    Am J Clin Dermatol; 2019 Dec; 20(6):763-770. PubMed ID: 31359351
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Next-Generation Sequencing Reveals Pathway Activations and New Routes to Targeted Therapies in Cutaneous Metastatic Melanoma.
    Carlson JA; Caldeira Xavier JC; Tarasen A; Sheehan CE; Otto G; Miller VA; Stephens PJ; Elvin JA; Vergilio JA; Suh J; Gay LM; Ross JS
    Am J Dermatopathol; 2017 Jan; 39(1):1-13. PubMed ID: 28045747
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative study of YKL-40, S-100B and LDH as monitoring tools for Stage IV melanoma.
    Egberts F; Kotthoff EM; Gerdes S; Egberts JH; Weichenthal M; Hauschild A
    Eur J Cancer; 2012 Mar; 48(5):695-702. PubMed ID: 21917447
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inflammation and Apolipoproteins Are Potential Biomarkers for Stratification of Cutaneous Melanoma Patients for Immunotherapy and Targeted Therapy.
    Karlsson MJ; Costa Svedman F; Tebani A; Kotol D; Höiom V; Fagerberg L; Edfors F; Uhlén M; Egyhazi Brage S; Maddalo G
    Cancer Res; 2021 May; 81(9):2545-2555. PubMed ID: 33574091
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Circulating tumor cells as prognostic biomarkers in cutaneous melanoma patients.
    Kiyohara E; Hata K; Lam S; Hoon DS
    Methods Mol Biol; 2014; 1102():513-22. PubMed ID: 24258996
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of serum lactate dehydrogenase level as a prognostic indicator in resected, high risk melanoma.
    Kumar AB; Aguilera JV; Velazquez A; Yan Y; Jakub J; Brewer J; Hieken T; Block M; McWilliams R; Otley C; Markovic S; Kottschade L
    Dermatol Ther; 2019 Mar; 32(2):e12813. PubMed ID: 30620137
    [No Abstract]   [Full Text] [Related]  

  • 40. Pathology of melanoma.
    Elder DE
    Surg Oncol Clin N Am; 2015 Apr; 24(2):229-37. PubMed ID: 25769708
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.